• ქართული
  • English
  • Factbox: The Galapagos drugs pipeline that has drawn in Gilead

    U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV .

    Market Quotes by TradingView